Erratum: Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting (European Journal of Cardio-thoracic Surgery (2003) 24 (547-551) DOI: 10.1016/S1010-7940(03)00394-4);Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 4, 2003, Pages 547-551

  Flynn, Michael J ^a,b   Winters, Desmond ^a   Breen, Patrick ^a   O'Sullivan, Gerry ^a   Shorten, George ^a   O'Connell, Damien ^a   O'Donnell, Aonghus ^a   Aherne, Thomas ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Dopamine A 1 receptor; Dopamine 2 receptor; Dopexamine; Graft flow; Left internal mammary artery; Saphenous vein graft

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPEXAMINE;

ADULT; AGED; ANESTHESIST; ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HEART INDEX; HEART LEFT VENTRICLE; HEART RATE; HUMAN; HYPOTHESIS; INOTROPISM; INTERNAL MAMMARY ARTERY; LOW DRUG DOSE; LUNG HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT;

EID: 0141515555     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2003.06.003     Document Type: Erratum

References (19)

1. Cracowski J.L., Chanavon O., Durand M., Borrel E., Devillier P., Mallion J.M., Blin D. Effect of low-dose positive inotropic drugs on human internal mammary artery flow. Ann Thorac Surg. 64:1997;1742-1746.
2. Dunardo J.A., Bert A., Schwartz M.J., Johnson R.G., Thurer R.L., Weintraub R.M. Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein in man. J Thorac Cardiovasc Surg. 102:1991;730-735.
3. Izzat M.B., West R.R., Ragoonan C., Angelini G.D. Effects of systemic vasodilators on internal mammary artery flow. J Thorac Cardiovasc Surg. 108:1994;82-85.
4. Von Segesser L.K., Lehmann K., Turina M. Deleterious effects of shock in internal mammary artery anastomoses. Ann Thorac Surg. 47:1989;575-579.
5. He G.W., Buxton B.F., Rosenfeldt F.L., Angus J.A., Tatoulis J. Pharmacological dilatation of the internal mammary artery during coronary bypass. J Thorac Cardiovasc Surg. 107:1994;1440-1444.
6. O'Connell D.P., Ozaro R. Localization of dopamine A-1 receptors in human heart and kidney. Hypertension. 30:(2):1997;725-729.
7. Lee-Myers M., Li G.H., Yaghi A., McCormack D. Human internal thoracic artery reactivity to dopaminergic agents. Circulation. 88:(Pt 2):1993;110-114.
8. Jett G.K., Arcidi J.M. Jr, Dorsey L., Hatcher C.R. Jr, Guyton R.A. Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts. J Thorac Cardiovasc Surg. 94:1987;2-11.
9. Biro G.P., Douglas J.R., Keon W.J., Taichman G.C. Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs. Am J Cardiol. 62:1988;30C-36C.
10. Arnaudov D., Cohen A., Zabeeda D., Hauptman E., Sasson L., Schachner A., Ezra S. Effect of systemic vasodilators on internal mammary flow during coronary bypass grafting. Ann Thorac Surg. 62:1996;1816-1819.
11. Canver C., Dame N. Ultrasonic assessment of internal thoracic artery graft flow in the revascularized heart. Ann Thorac Surg. 58:1994;135-138.
12. Foulds R. Clinical development of dopexamine hydrochloride and an overview of its hemodynamic effects. Am J Cardiol. 62:1988;41C-45C.
13. Jackson N.C., Taylor S.H., Frais M.A. Hemodynamic comparison of dopexamine hydrochloride and dopamine in ischemic left ventricular dysfunction. Am J Cardiol. 62:1988;73C-77C.
14. Van Der Starre P., Rosseel P. Dopexamine hydrochloride after coronary artery bypass grafting. Am. J Cardiol. 62:1988;78C-82C.
15. Canver C.C., Dame N. Is free flow measurement of the internal thoracic artery accurate? Ann Thorac Surg. 62:1994;1248.
16. Hurley J., McDonagh P., Cahill M., Luke D., McGovern E., Phelan D. The haemodynamic effect of prophylactic peri-operative dopexamine in coronary artery bypass patients. Eur Heart J. 16:(11):1995;1705-1709.
17. Halpenny M., Lakshmi S., O'Donnell A., O'Callaghan-Enright S., O'Connell D., Shorten G. The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 15:(1):2001;72-76.
18. Halpenny M., Lakshmi S., O'Donnell A., O'Callaghan-Enright S., Shorten G. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia. 56:(10):2001;953-957.
19. Murphy C., Chih P., Gott J., Guyton R. Microvascular reactivity after crystalloid, cold blood and blood cardioplegic arrest. Ann Thorac Surg. 60:1995;1021-1027.